Home Newsfeeds BMO Capital Maintains Outperform on Dynatrace, Raises Price Target to $49

BMO Capital Maintains Outperform on Dynatrace, Raises Price Target to $49

BMO Capital analyst Keith Bachman maintains Dynatrace (NYSE:DT) with a Outperform and raises the price target from $42 to $49.

byBenzinga Newsdesk

August 4, 2022

1 minute read

BMO Capital analyst Keith Bachman maintains Dynatrace (NYSE:DT) with a Outperform and raises the price target from $42 to $49.

News

Euronet Worldwide Expands ATM Network Into Southeast Asia

By Benzinga Newsdesk

October 4, 9:17 AM

LEAWOOD, Kan., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Euronet Worldwide Inc. (NASDAQ:EEFT), a leading global financial technology solutions and payments provider, announced today the expansion of its ATM network into

EEFT

Foot Locker Needs More Time To Adapt To Recent Abrupt Industry Challenges, Says Credit Suisse Analyst

By Shivani Kumaresan

November 16, 1:55 PM

Credit Suisse analyst Michael Binetti reiterated a Neutral rating on the shares of Foot Locker Inc (NYSE:FL) and lowered the price target…

ADDYY

Surmodics Provides Regulatory Update Related To Its FDA Premarket Approval Application For The SurVeil Drug-Coated Balloon

By Benzinga Newsdesk

January 19, 8:01 AM

Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced it has received a letter from the U.S. Food and Drug Administration

SRDX

News

NeoVolta, Solar Battery Manufacturer, Slated To Join Russell Microcap Index

By Benzinga Newsdesk

June 13, 8:46 AM

NeoVolta (NASDAQ:NEOV), a solar battery manufacturer and developer of smart residential energy storage solutions, will join the Russell Microcap® Index following the 2023 Russell indexes annual reconstitution, which

NEOV

BMO Capital Maintains Outperform on Dynatrace, Raises Price Target to $49

Related Posts

Euronet Worldwide Expands ATM Network Into Southeast Asia

Foot Locker Needs More Time To Adapt To Recent Abrupt Industry Challenges, Says Credit Suisse Analyst

Surmodics Provides Regulatory Update Related To Its FDA Premarket Approval Application For The SurVeil Drug-Coated Balloon

NeoVolta, Solar Battery Manufacturer, Slated To Join Russell Microcap Index